The CEO, Todd MacLaughlan, of Profounda, Inc. recently did a Reddit AMA[1] about this new drug.<p>Profunda, Inc. is trying to distribute this drug in as many hospitals as possible to make sure no one goes without treatment.<p>"Naegleria fowleri (commonly known as the “Brain eating Amoeba”) causes a brain infection called Primary Amebic Meningoencephalitis (PAM) that is almost always fatal (97%). In the United States only three people had ever survived PAM. Two of them were on Miltefosine, our newly acquired drug (It’s FDA indication is for the treatment of Leishmaniasis- a rare tropical disease). Sebastian Deleon marks the 4th survivor and the 3rd on our medication." - His words from his AMA.<p>[1]<a href="https://www.reddit.com/r/IAmA/comments/4zdc5a/iama_pharma_company_ceo_whose_drug_just_helped/" rel="nofollow">https://www.reddit.com/r/IAmA/comments/4zdc5a/iama_pharma_co...</a>